Carter Bankshares, Inc. (CARE) Revenue History
Annual and quarterly revenue from 2007 to present
CARE Revenue Over Time (2007–2025)
CARE Revenue Growth History
11 of 18 years with positive growth- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- -4.0%
- FY2009 revenue growth
- +4.8%
- FY2010 revenue growth
- +4.9%
- FY2011 revenue growth
- -0.7%
- FY2012 revenue growth
- +2.2%
- FY2013 revenue growth
- -5.9%
- FY2014 revenue growth
- +0.6%
- FY2015 revenue growth
- +3.4%
- FY2016 revenue growth
- -10.9%
- FY2017 revenue growth
- -1.6%
- FY2018 revenue growth
- +9.4%
- FY2019 revenue growth
- +6.6%
- FY2020 revenue growth
- -2.7%
- FY2021 revenue growth
- -4.5%
- FY2022 revenue growth
- +14.6%
- FY2023 revenue growth
- +18.2%
- FY2024 revenue growth
- +13.1%
- FY2025 revenue growth
- +6.2%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $64.5M | — |
| Q3 2025 | $63.6M | — |
| Q2 2025 | $61.7M | — |
| Q1 2025 | $61.9M | — |
| Q4 2024 | $60.9M | — |
| Q3 2024 | $61.1M | — |
| Q2 2024 | $59.3M | — |
| Q1 2024 | $58.3M | — |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
CARE's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
CARE Revenue Analysis (2007–2025)
Current Revenue & Growth
As of June 21, 2026, Carter Bankshares, Inc. (CARE) generated trailing twelve-month (TTM) revenue of $251.7 million, reflecting solid growth of +5.9% year-over-year. The most recent quarter (Q4 2025) recorded $64.5 million in revenue, up 1.5% sequentially.
Historical Growth Trajectory
CARE's 5-year compound annual growth rate (CAGR) stands at +9.2%, indicating steady revenue expansion. The 3-year CAGR of +12.4% exceeds the 5-year average, indicating an acceleration in the most recent period. Carter Bankshares, Inc.'s highest annual revenue of $254.6 million was recorded in 2025, an all-time high.
Revenue by Segment
CARE's revenue is primarily driven by Bank Owned Life Insurance Income (74%), and Other Revenue (26%). With over half of revenue concentrated in Bank Owned Life Insurance Income, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Financial Services sector peers — including NBTB, UVSP, and NFBK. Compare CARE vs NBTB →
CARE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CARECurrent | $252M | +5.9% | +9.2% | 15.7% | |
 NBTB | $867M | - | - | 25.3% | |
 UVSP | $518M | - | - | 21.9% | |
 NFBK | $184M | - | - | 9.3% | |
 MNSB | $136M | - | - | 14.0% | |
 NKSH | $85M | - | - | 22.5% |
CARE Historical Revenue Data (2007–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $254.6M | - | $157.1M | 61.7% | $40.0M | 15.7% |
| 2024 | $239.7M | - | $137.4M | 57.3% | $30.9M | 12.9% |
| 2023 | $211.8M | - | $131.3M | 62.0% | $28.7M | 13.6% |
| 2022 | $179.2M | - | $156.0M | 87.1% | $61.7M | 34.4% |
| 2021 | $156.4M | - | $131.6M | 84.1% | $35.7M | 22.8% |
| 2020 | $163.8M | - | $109.9M | 67.1% | $-45,086,000 | -27.5% |
| 2019 | $168.4M | - | $118.2M | 70.2% | $27.8M | 16.5% |
| 2018 | $157.9M | - | $102.9M | 65.2% | $14.3M | 9.1% |
| 2017 | $144.3M | - | $64.0M | 44.4% | $-18,212,000 | -12.6% |
| 2016 | $146.7M | - | $82.6M | 56.3% | $17.6M | 12.0% |
| 2015 | $164.6M | - | $113.5M | 69.0% | $49.4M | 30.0% |
| 2014 | $159.1M | - | $110.8M | 69.6% | $43.3M | 27.2% |
| 2013 | $158.2M | - | $102.7M | 64.9% | $35.2M | 22.2% |
| 2012 | $168.1M | - | $109.2M | 65.0% | $41.1M | 24.5% |
| 2011 | $164.6M | - | $106.1M | 64.5% | $38.3M | 23.3% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
19+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CARE — Frequently Asked Questions
Quick answers to the most common questions about buying CARE stock.
Is CARE's revenue growth accelerating or slowing?
CARE revenue growth is holding steady at +5.9% year-over-year. TTM revenue is $252M. The current growth rate closely tracks the 5-year CAGR of +9.2%, signalling consistent execution.
What is CARE's revenue history from 2007 to 2026?
Carter Bankshares, Inc. (CARE) revenue history spans 2007 to 2026. TTM revenue as of 2026 is $252M, growing at +5.9% YoY. The 5-year CAGR is +9.2%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is CARE's long-term revenue growth rate (CAGR)?
Carter Bankshares, Inc.'s 5-year revenue CAGR of +9.2% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +5.9% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CARE.
Why does CARE's quarterly revenue fluctuate?
CARE quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Carter Bankshares, Inc.'s revenue data from 2007 to 2026 shows full historical quarterly detail on this page.
How is CARE's revenue distributed by segment?
CARE reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does CARE's revenue compare to industry peers?
Carter Bankshares, Inc. (CARE) with TTM revenue of $252M and +5.9% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.